Pulmatrix, Inc.
PULM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001574235
No open-market purchases or sales by Pulmatrix, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $568.7K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Pulmatrix, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 20 | 1 | 24 | +5 |
| Shares | 7.68M | 359.4K | 12.3M | +4.93M (+67.4%) |
| Value | $6.14M | $288.0K | $5.36M | −$494.4K (−8.4%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Pulmatrix, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 3,617,043 | $1.58M | 0.40% |
| Hudson Bay Capital Management LP | 1,525,000 | $667.0K | 0.01% |
| Virtu Financial LLC | 131,896 | $58.0K | 0.01% |
| Murchinson Ltd. | 100,000 | $44.0K | 0.00% |
| ARCH Venture Management, LLC | 43,639 | $19.0K | 0.00% |
| Barclays PLC | 98 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 566 | $0 | 0.00% |
| Tyler-Stone Wealth Management | 90 | $0 | 0.00% |
Sold out (3)
Institutions that held Pulmatrix, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Winton Group Ltd | 61,588 | $49.0K |
| Citadel Advisors LLC | 42,557 | $34.0K |
| Two Sigma Securities, LLC | 13,786 | $11.0K |
Not filed for Q4 2021 yet (1)
Institutions that held Pulmatrix, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 359,441 | $288.0K |